[AGN] Allergan plc.


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 96.6 B

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 198.87 Change: 4.89 (2.52%)
Ext. hours: Change: 0 (0%)

chart AGN

Refresh chart

Strongest Trends Summary For AGN

AGN is in the long-term up 647% in 18 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding395.56 M EPS EPS Growth - 4 Quarters115.47% EPS Growth - Q/Q75.5%
EPS Growth - Y/Y58.22% Sales Growth - 4 Quarters 16.06% Sales Growth - Q/Q5.14% P/E
P/E To EPS Growth0.57 P/S13.35 P/BV12.46 Price/Cash Per Share19.45
Price/Free Cash Flow57.37 ROA12.28% ROE19.66% ROI14.05%
Current Ratio4.41 Quick Ratio4.22 Long Term Debt/Equity0.39 Debt Ratio0.2
Gross Margin88.36% Operating Margin27.76% Net Profit Margin21.06% Dividend Payout Ratio-3.91%
Dividend Yield-0.06%
Fundamental Data
Cash From Financing Activities Cash From Investing Activities183.4 M Cash From Operating Activities144.6 M Gross Profit1.7 B
Net Profit694.2 M Operating Profit626.7 M Total Assets12.42 B Total Current Assets6.87 B
Total Current Liabilities1.56 B Total Debt2.09 B Total Liabilities4.66 B Total Revenue1.91 B
Technical Data
High 52 week254.35 Low 52 week163.58 Last close181.33 Last change0.94%
RSI76.15 Average true range4 Beta0.66 Volume3.21 M
Simple moving average 20 days5.72% Simple moving average 50 days5.79% Simple moving average 200 days-14.33%
Performance Data
Performance Week2.38% Performance Month6.1% Performance Quart-2.72% Performance Half-26.68%
Performance Year-14.39% Performance Year-to-date10.85% Volatility daily1.51% Volatility weekly3.37%
Volatility monthly6.91% Volatility yearly23.95% Relative Volume226.12% Average Volume3.42 M
New High New Low


2019-06-17 08:29:32 | 3 Big Stock Charts for Monday: Centurylink, Allergan and Charles Schwab

2019-06-15 10:07:07 | Allergan plc's NYSE:AGN Profit Outlook

2019-06-14 08:34:12 | Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti

2019-06-12 15:50:40 | Pharmaceutical giant Allergan expands in Northwest Austin

2019-06-12 10:23:00 | Short Sellers Are Making Bigger Bets Against Teva and Allergan Stock

2019-06-11 08:02:01 | See what the IHS Markit Score report has to say about Allergan plc.

2019-06-10 16:10:49 | Is Allergan plc AGN A Good Stock To Buy ?

2019-06-10 09:39:01 | TherapeuticsMD Enters Agreement to Market Drugs Outside US

2019-06-07 05:19:00 | 7 Stocks Ripe for M&A as Trade War Pushes Market Off Record Highs

2019-06-06 09:31:01 | Allergan AGN Down 9.7% Since Last Earnings Report: Can It Rebound?

2019-06-05 09:50:01 | Ironwood Initiates Dosing in Mid-Stage Study for MD-7246

2019-06-03 14:00:00 | Watch These 9 Companies in a Botox Export Boom Out of South Korea

2019-05-29 16:15:00 | Johnson & Johnson Stock Falls as Its Opioid Trial Gets Underway

2019-05-29 10:34:02 | Allergan's AGN Vraylar Gets FDA Nod for Bipolar Depression

2019-05-28 16:58:09 | Allergan to recall textured breast implants in Canada

2019-05-28 12:21:27 | Allergan's Vraylar wins U.S. FDA approval for bipolar depression

2019-05-28 11:48:03 | Conatus Down More Than 60% in the Past 90 Days: Here's Why

2019-05-28 07:30:00 | Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® cariprazine in the Treatment of Bipolar Depression

2019-05-24 16:05:00 | Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference

2019-05-23 10:54:54 | David Tepper To Turn Appaloosa Into A Family Office, Focus On Family And Panthers

2019-05-23 09:15:14 | Micron, PG&E, Allergan, Amazon Among Appaloosa's Top Holdings

2019-05-23 07:30:00 | Allergan to Present at the Jefferies 2019 Healthcare Conference

2019-05-22 14:22:44 | He's one of NYC's youngest VCs: Get to know Gen Z investor Patrick Finnegan

2019-05-20 13:18:09 | Time to buy ArcelorMittal? Any interest in Alibaba? What about Fitbit? The viewers #AskHalftime

2019-05-17 07:30:00 | Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis

2019-05-16 09:20:15 | Consider This Before Buying Allergan plc NYSE:AGN For The 2.2% Dividend

2019-05-16 07:30:00 | Allergan to Present at the Bernstein Strategic Decisions Conference

2019-05-15 17:08:13 | Wallace Weitz Exits Allergan, Trims Liberty Broadband Position

2019-05-15 07:30:00 | Allergan to Present VRAYLAR® cariprazine Data at the American Psychiatric Association APA 2019 Annual Meeting Highlighting Continued Commitment to Mental Health

2019-05-15 06:00:00 | PatientFi® Announces Study Partnership with Allergan

2019-05-13 15:00:59 | Leidos feels effects of a nationally known ‘corporate gadfly’

2019-05-13 09:27:50 | 5 Growthy Biotech Stocks to Buy Despite the Scrutiny

2019-05-10 07:34:11 | Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug

2019-05-09 07:30:00 | Allergan to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

2019-05-08 15:17:54 | Botox Competitor Aims to Take Market Share as Allergan Stumbles

2019-05-08 08:30:03 | Edited Transcript of AGN earnings conference call or presentation 7-May-19 12:30pm GMT

2019-05-07 16:32:20 | Allergan Fended Off Botox Rivalries In The First Quarter — But Can It Last?

2019-05-07 16:15:00 | Allergan stock slips despite revenue beat, a sign of investors’ worries over company’s future

2019-05-07 15:21:27 | Epipen Parent's Faceplant Is a Cautionary Tale for Botox Maker

2019-05-07 15:00:00 | What You Need to Know About Allergan's Solid Q1 Performance

2019-05-07 13:23:31 | Allergan PLC AGN Q1 2019 Earnings Call Transcript

2019-05-07 13:20:00 | Regeneron Stock Could Fall 13% to 52-Week Lows

2019-05-07 12:20:29 | Allergan CEO says company is urgently looking at all options to boost share price

2019-05-07 09:51:00 | Allergan Tops Q1 Earnings Estimate, Boosts Full-Year Profit Outlook

2019-05-07 09:27:01 | Allergan AGN Beats on Q1 Earnings & Sales, Raises '19 View

2019-05-07 08:59:00 | Allergan Stock Slips Despite Beat and Raised Guidance

2019-05-07 08:25:12 | Allergan AGN Q1 Earnings and Revenues Top Estimates

2019-05-07 07:59:27 | Stocks making the biggest moves premarket: Ferrari, Boeing, PepsiCo, Mosaic, Hertz, AIG & more

2019-05-07 07:49:47 | Allergan lifts outlook after Botox plumps quarterly earnings

2019-05-07 07:34:00 | Allergan stock down 0.5% despite earnings and revenue beat